Showing 1 - 4 results of 4 for search 'James P. Buteau', query time: 0.03s
Refine Results
-
1
-
2
-
3
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol) by Louise Kostos, Louise Kostos, James P. Buteau, James P. Buteau, James P. Buteau, Theresa Yeung, Juliana Di Iulio, Jing Xie, Anthony Cardin, Anthony Cardin, Anthony Cardin, Kwang Y. Chin, Kwang Y. Chin, Brittany Emmerson, Brittany Emmerson, Katie L. Owen, Katie L. Owen, Belinda S. Parker, Belinda S. Parker, Heidi Fettke, Heidi Fettke, Luc Furic, Luc Furic, Arun A. Azad, Arun A. Azad, Michael S. Hofman, Michael S. Hofman, Michael S. Hofman
Published 2022-11-01
Article -
4
Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review by Duncan E. K. Sutherland, Raghava Kashyap, Price Jackson, James P. Buteau, Declan G. Murphy, Brian Kelly, Lavinia Spain, Shahneen Sandhu, Arun A. Azad, Elizabeth Medhurst, Grace Kong, Michael S. Hofman
Published 2023-06-01
Article